## FDS: FactSet Research Systems Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 1.0% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (53% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($275.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Copeland Capital Management LLC Boosts Stake in FactSet Research Systems Inc. $FDS**
- Source: MarketBeat | 20251230T101419 | Neutral | Relevance: 100%
- Copeland Capital Management LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS) by 24.6% to 72,369 shares, valued at approximately $20.73 million. Despite the company beating quarterly expectations with EPS of $4.51 and revenue of $607.6 million, and authorizing a $600 million share buyback, the consensus analyst rating remains "Reduce" with a target price of $313.17. FactSet also offers a quarterly dividend of $1.10, yielding about 1.5%, and has seen recent insider stock purchases.

**2. Boston Trust Walden Corp Sells 7,189 Shares of FactSet Research Systems Inc. $FDS**
- Source: MarketBeat | 20251229T100810 | Somewhat-Bullish | Relevance: 100%
- Boston Trust Walden Corp reduced its stake in FactSet Research Systems Inc. ($FDS) by 2.4%, selling 7,189 shares and now holding 290,323 shares valued at approximately $83.18 million. FactSet exceeded earnings expectations with $4.51 EPS and set a robust FY 2026 guidance, while also authorizing a $600 million share buyback and maintaining a $1.10 quarterly dividend. The company currently holds a "Reduce" consensus rating from analysts with a $313.17 price target.

**3. Redwire stock edges up in premarket after 13% jump; RDW traders watch $8 level**
- Source: ts2.tech | 20251231T120933 | Neutral | Relevance: 64%
- Redwire Corporation (RDW) shares rose 0.8% to $8.00 in premarket trading on Wednesday, following a significant 13.43% rally in the previous session. The price movement comes after a mid-December contract win for its space and defense technology offerings. Traders are closely watching the $8 level as early trading relies more on positioning and technical levels, with no new fundamental news since their last contract announcement.

**4. ModivCare Completes Asset Transfer and Exit Financing**
- Source: TradingView â€” Track All Markets | 20251229T210849 | Neutral | Relevance: 61%
- ModivCare (MODVQ) completed significant restructuring on December 29, 2025, by transferring substantially all its assets to a buyer and securing an Exit Term Loan Credit Agreement. This financing will fund operations and plan distributions, replacing prior credit facilities and debtor-in-possession financing under its confirmed Chapter 11 plan. The new capital structure includes $400 million in exit term loans maturing in December 2030, ensuring post-emergence liquidity and aligning ownership with stakeholders.

**5. Best Buy Co. Inc. stock underperforms Monday when compared to competitors**
- Source: MarketWatch | 20251229T163000 | Neutral | Relevance: 61%
- Best Buy Co. Inc. (BBY) stock declined by 2.54% on Monday, closing at $67.84, amidst a broader market downturn where the S&P 500 Index and Dow Jones Industrial Average also fell. This marks the second consecutive day of losses for the company's shares.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 1, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | BMO Capital | $305 | $311 | -2% |
| 2025-12-19 | Goldman Sachs | $253 | $282 | -10% |
| 2025-12-19 | RBC Capital | $320 | $320 | 0% |
| 2025-12-19 | Stifel | $295 | $372 | -21% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | BMO Capital | main | Market Perform |
| 2025-12-19 | Goldman Sachs | main | Sell |
| 2025-12-19 | RBC Capital | reit | Sector Perform |
| 2025-12-19 | Stifel | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 14 ($0.23M) |
| Sells | 8 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.1% (+1.2%)
- Ninety One UK Ltd: 6.5% (+102.4%)
- Morgan Stanley: 5.8% (-8.7%)
- State Street Corpora: 5.2% (+1.2%)

### Key Risks

1. Long-term trend broken: trading 21.5% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 29%, ROA 11%, margin 25%). Analyst sentiment negative (4 target cuts vs 1 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.0B |
| Beta | 0.74 |
| 52W Range | $250.50 - $484.33 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 15.3 |
| Current P/E | 16.6 |
| YoY Growth | 8.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 3.0pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Below SMA200 (0.79x), long-term trend not supportive. RSI neutral at 54. Volume at 53% of 20MA suggests lack of conviction. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.04% (CS: 70) | Neutral |
| RSI_14 | 53.7 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.036x | Above |
| vs SMA200 | 0.785x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $290.20
- **Stop Loss:** $275.16 (5.2% risk)
- **Target:** $305.24 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 59
- **Position Value:** $17,121.80
- **Portfolio %:** 17.12%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.36 | $4.51 | +3.5% |
| 2025Q3 | $4.13 | $4.05 | -1.9% |
| 2025Q2 | $4.30 | $4.27 | -0.6% |
| 2025Q1 | $4.18 | $4.28 | +2.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*